| scholarly article | Q13442814 |
| P50 | author | Lawrence W. Chamley | Q39050378 |
| Jan J. Brosens | Q37618319 | ||
| P2093 | author name string | Vikki M Abrahams | |
| Jane E Salmon | |||
| Marta Guerra | |||
| Melissa J Mulla | |||
| Stefan M Gysler | |||
| P2860 | cites work | Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta | Q24613616 |
| MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells | Q24645977 | ||
| Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals | Q24649064 | ||
| Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature | Q38332194 | ||
| Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome | Q38333095 | ||
| Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. | Q38516599 | ||
| MicroRNA-155 inhibits migration of trophoblast cells and contributes to the pathogenesis of severe preeclampsia by regulating endothelial nitric oxide synthase | Q38997409 | ||
| Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function | Q39044818 | ||
| MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. | Q39303428 | ||
| MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides | Q39553937 | ||
| Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. | Q39743504 | ||
| Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women? | Q39821048 | ||
| Reduced circulating miR-196b levels is associated with preeclampsia. | Q40806450 | ||
| Housekeeping genes for studies of plasma microRNA: A need for more precise standardization | Q40816584 | ||
| Synthesis of beta2 glycoprotein 1 by the human placenta | Q41101472 | ||
| Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. | Q41924274 | ||
| Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure? | Q42511087 | ||
| Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan | Q42804803 | ||
| Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes | Q47354685 | ||
| Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice | Q47725162 | ||
| Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. | Q47758501 | ||
| microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages | Q47781337 | ||
| miRNA in plasma exosome is stable under different storage conditions. | Q50692718 | ||
| Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. | Q53250090 | ||
| MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. | Q54733079 | ||
| Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure | Q57523494 | ||
| Antiphospholipid antibodies prevent extravillous trophoblast differentiation | Q60273555 | ||
| The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts | Q79842633 | ||
| TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss | Q81178348 | ||
| Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity | Q82782633 | ||
| MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins | Q83586463 | ||
| Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells | Q84513241 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| MicroRNAs and their isomiRs function cooperatively to target common biological pathways | Q27499590 | ||
| The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
| Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort | Q28741729 | ||
| MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response | Q29615493 | ||
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts | Q30496174 | ||
| Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome | Q33630007 | ||
| Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation | Q34103235 | ||
| MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. | Q34114198 | ||
| miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells | Q34138772 | ||
| Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus | Q34144124 | ||
| A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast. | Q34769721 | ||
| Identification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA. | Q35021710 | ||
| Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia | Q35236547 | ||
| Viral single stranded RNA induces a trophoblast pro-inflammatory and antiviral response in a TLR8-dependent and -independent manner | Q35617081 | ||
| Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm Labor | Q35930887 | ||
| Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies | Q35977256 | ||
| New facet of antiphospholipid antibodies | Q36242855 | ||
| Immunomodulatory molecules are released from the first trimester and term placenta via exosomes | Q36501381 | ||
| ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice | Q36619367 | ||
| The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. | Q36759672 | ||
| TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4 pathway | Q36976363 | ||
| Human placental trophoblasts confer viral resistance to recipient cells | Q37031670 | ||
| Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer | Q37083534 | ||
| miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. | Q37271482 | ||
| Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease | Q37295740 | ||
| Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway | Q37409260 | ||
| Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study | Q37420173 | ||
| The role of placental exosomes in reproduction | Q37717747 | ||
| MicroRNAs: the fine-tuners of Toll-like receptor signalling | Q37844405 | ||
| Obstetric and vascular APS: same autoantibodies but different diseases? | Q38013583 | ||
| Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? | Q38175887 | ||
| P433 | issue | 7 | |
| P921 | main subject | interleukins | Q194908 |
| toll-like receptor | Q408004 | ||
| P304 | page(s) | 465-474 | |
| P577 | publication date | 2016-03-29 | |
| P1433 | published in | Molecular Human Reproduction | Q15761794 |
| P1476 | title | Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. | |
| P478 | volume | 22 |
| Q49998565 | Antiphospholipid Antibodies Inhibit Trophoblast Toll-like Receptor and Inflammasome Negative Regulators. |
| Q64939287 | Effect of Hypoxia-Induced MicroRNA-210 Expression on Cardiovascular Disease and the Underlying Mechanism. |
| Q39264755 | Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation |
| Q92756215 | Exosomes-Associated DNA-New Marker in Pregnancy Complications? |
| Q90350534 | Extracellular vesicles in normal pregnancy and pregnancy-related diseases |
| Q49456387 | Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease |
| Q64108214 | New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches |
| Q90432999 | Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders |
| Q90059408 | Roles of pattern recognition receptors in diabetic nephropathy |
| Q39305388 | SASP regulation by noncoding RNA. |
| Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
| Q93020058 | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
| Q52323268 | Toll-like receptors in lupus nephritis. |
| Q38731888 | miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2. |
Search more.